# SERENTIL
> **NDA016774** · New Drug Application · Sponsor: NOVARTIS · Approved 1970-02-27
## Drug
- **FDA Application Number:** NDA016774
- **Application type:** New Drug Application
- **Brand name:** SERENTIL
- **Generic name:** Mesoridazine Besylate
- **Active ingredients:** MESORIDAZINE BESYLATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** NOVARTIS
- **First approval:** 1970-02-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016774)
---
*AI Analytics · CC0 1.0*